Integragen (France) Price Patterns
| ALINT Stock | EUR 0.18 0.01 5.88% |
Momentum 55
Impartial
Oversold | Overbought |
Quarterly Earnings Growth (0.34) | Wall Street Target Price 3.9 | Quarterly Revenue Growth (0.40) |
Using Integragen hype-based prediction, you can estimate the value of Integragen from the perspective of Integragen response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Integragen to buy its stock at a price that has no basis in reality. In that case, they are not buying Integragen because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Integragen after-hype prediction price | EUR 0.18 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Integragen |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Integragen's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Integragen After-Hype Price Density Analysis
As far as predicting the price of Integragen at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Integragen or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Integragen, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Integragen Estimiated After-Hype Price Volatility
In the context of predicting Integragen's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Integragen's historical news coverage. Integragen's after-hype downside and upside margins for the prediction period are 0.01 and 7.38, respectively. We have considered Integragen's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Integragen is out of control at this time. Analysis and calculation of next after-hype price of Integragen is based on 3 months time horizon.
Integragen Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Integragen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Integragen backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Integragen, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.76 | 7.20 | 0.00 | 0.03 | 4 Events / Month | 2 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.18 | 0.18 | 0.00 |
|
Integragen Hype Timeline
Integragen is presently traded for 0.18on Euronext Paris of France. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.03. Integragen is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is presently at 0.76%. %. The volatility of related hype on Integragen is about 19297.78%, with the expected price after the next announcement by competition of 0.15. About 66.0% of the company shares are held by company insiders. The book value of Integragen was presently reported as 0.29. The company recorded a loss per share of 0.04. Integragen had not issued any dividends in recent years. Assuming the 90 days trading horizon the next projected press release will be in about 4 days. Check out Integragen Basic Forecasting Models to cross-verify your projections.Integragen Related Hype Analysis
Having access to credible news sources related to Integragen's direct competition is more important than ever and may enhance your ability to predict Integragen's future price movements. Getting to know how Integragen's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Integragen may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GNRO | Geneuro SA | 0 | 4 per month | 0.00 | (0.02) | 11.11 | (8.79) | 46.12 | |
| TNG | Transgene SA | (0.01) | 4 per month | 0.00 | (0.15) | 5.43 | (5.10) | 26.23 | |
| ALBPS | Biophytis SA | (0.01) | 3 per month | 0.00 | (0.15) | 3.81 | (6.71) | 44.52 | |
| ALGAE | ALGAE | (0.04) | 1 per month | 0.00 | (0.08) | 4.76 | (4.55) | 15.42 | |
| GNFT | Genfit SA | 0.14 | 3 per month | 1.49 | 0.34 | 6.09 | (3.96) | 14.69 | |
| ALSEN | Sensorion SA | 0.00 | 3 per month | 0.00 | (0.03) | 6.45 | (6.06) | 29.32 | |
| IPH | Innate Pharma | 0.01 | 4 per month | 0.00 | (0.05) | 3.01 | (3.01) | 31.58 | |
| AELIS | Aelis Farma SA | (0.49) | 1 per month | 4.55 | 0.08 | 6.60 | (6.16) | 54.01 | |
| ALDVI | Advicenne | 0.01 | 7 per month | 2.28 | 0.09 | 6.93 | (4.21) | 17.98 | |
| DBV | DBV Technologies SA | 0.01 | 8 per month | 3.90 | 0.11 | 12.54 | (7.67) | 28.62 |
Integragen Additional Predictive Modules
Most predictive techniques to examine Integragen price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Integragen using various technical indicators. When you analyze Integragen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Integragen Predictive Indicators
The successful prediction of Integragen stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Integragen, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Integragen based on analysis of Integragen hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Integragen's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Integragen's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 125.26 | 132.44 | 152.3 | 162.67 | PTB Ratio | 2.94 | 2.17 | 2.49 | 2.37 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Integragen Stock Analysis
When running Integragen's price analysis, check to measure Integragen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integragen is operating at the current time. Most of Integragen's value examination focuses on studying past and present price action to predict the probability of Integragen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integragen's price. Additionally, you may evaluate how the addition of Integragen to your portfolios can decrease your overall portfolio volatility.